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Methods: We identified consecutive CAS procedures from 2009 to 2017 and compared those performed with and without 3D image fusion. For image fusion, we created a 3D reconstruction of the aortic arch based on preoperative computed tomography or magnetic resonance angiography that we merged with live fluoroscopy, providing 3D image overlay. We compared radiation exposure, fluoroscopy time, contrast dose, time to common carotid artery (CCA) cannulation, time from CCA cannulation to completion angiogram, and total procedure time in procedures with and without image fusion. We also assessed rates of 30-day stroke/death and acute kidney injury. We used multivariable linear regression to adjust for patient and procedural characteristics, and used these models to compute the marginal effects of image fusion use.
Results: Forty-six patients underwent CAS with 3D image fusion and 70 without. Patients undergoing CAS with image fusion experienced 31% lower radiation exposure compared with the control group (207 6 22.7 mGy vs 300 6 25.6 mGy, respectively; P < .01), shorter fluoroscopy time (20.8 6 6.2 minutes vs 23.9 6 8.2 minutes; P ¼ .02), shorter time to carotid cannulation (21.4 6 9.1 minutes vs 30.9 6 8.2 minutes; P < .001), and shorter total procedure time (47.0 6 13.1 minutes vs 53.9 6 17.8 minutes; P ¼ .03). There was no difference in contrast volume or time from CCA cannulation to completion angiogram. After multivariable adjustment, 3D image fusion remained associated with lower radiation dose, shorter fluoroscopy time, and shorter time to carotid cannulation (all P < .05; Fig) . The rate of 30-day stroke/death was 2.7% (three strokes and no deaths at 30 days), and the rate of acute kidney injury was 1.8%.
Conclusions: CAS with 3D image fusion is associated with a lower radiation exposure and shorter time to CCA cannulation. These results indicate the potential technical advantage gained with image fusion during this complex endovascular procedure. Although too early into its implementation to confirm, this technology also may decrease stroke risk during CAS by minimizing manipulation of the aortic arch. Objectives: Transcarotid artery revascularization (TCAR) provides an attractive alternative to carotid endarterectomy (CEA) and transfemoral stenting for high-risk patients by using a direct carotid approach with cerebral blood flow reversal for embolic protection. The purpose of this study was to compare outcomes from patients with carotid artery stenoses treated by TCAR versus a matched control group undergoing CEA.
Methods: The records of all patients who underwent TCAR at 3 institutions between 2013 and 2017 were retrospectively reviewed. TCAR patients had high-risk factors and were enrolled in prospective trials (ROADSTER 1, ROADSTER 2) or were treated after US Food and Drug Administration approval of the Enroute Neuroprotection System (Silk Road Medical, Inc, Sunnyvale, Calif). Contemporaneous patients undergoing CEA at each institution were also reviewed. Patients were matched in a 2:1 (CEA:TCAR) fashion with respect to age at time of surgery (3 years), gender, and symptomatic status. Data was analyzed using univariate statistical models with P < .05 considered significant.
Results: Overall, 789 patients (Table) were identified. In the entire cohort, patients undergoing the TCAR procedure were higher risk patients with an increased prevalence of diabetes (P ¼ .018), coronary artery disease (P < .001), and tobacco use (P ¼ .020) compared with CEA patients. Stroke rates at 30 days (1.4% vs 1.8%) and 1 year (2.9% vs 1.8%) were not statistically different between the groups. However, mortality was significantly higher in the CEA group at 30 days (1.9% vs 0%; P ¼ .04) and 1 year (6.6% vs 1.8%; P ¼ .04). When matched 2:1, a cohort of 501 patients (167 TCAR, 334 CEA) with mean follow-up of 28.7 months (range, 3-59 months) remained. Patients undergoing TCAR were treated pharmacologically more aggressively with both preoperative and postoperative aspirin (P < .001), clopidogrel (P < .001), and statins (P < .001). Stroke rates were 2.4% CEA versus 1.8% TCAR at 30 days and 3.6 versus 1.8% at 1 year (P ¼ NS). Hematoma, cranial nerve injury, and myocardial 
